drug
DEXMEDETOMIDINE HYDROCHLORIDE
Marketedupdated 3mo agoby HQ Speciality Pharma
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval28 co-mentions · 14 sources
- drugdexmedetomidine22 co-mentions · 19 sources
- drugIGALMI22 co-mentions · 19 sources
- tagDrug Shortage5 co-mentions · 5 sources
- companyBaxter Healthcare Corp1 co-mentions · 1 sources
- company$PFEPFIZER INC1 co-mentions · 1 sources
- companyMylan Institutional Inc1 co-mentions · 1 sources
- companyAccord Healthcare Inc1 co-mentions · 1 sources
all catalysts(10)
approval · 10
Aug 20, 2015
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Aug 25, 2017
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Aug 25, 2017
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Nov 23, 2020
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Feb 19, 2021
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Feb 17, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Mar 9, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Mar 20, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Mar 20, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Apr 15, 2026
approval
DEXMEDETOMIDINE HYDROCHLORIDE — FDA approval
DEXMEDETOMIDINE HYDROCHLORIDE
→
Trials studying DEXMEDETOMIDINE HYDROCHLORIDE
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 4, 2032
~5.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (42)
- Apr 20, 2036formulationUS 9649296
- Apr 20, 2036formulationUS 9649296
- Apr 20, 2036formulationUS 9717796
- Apr 20, 2036formulationUS 9717796
- Jul 4, 2032patentUS 8242158*PED
- Jul 4, 2032patentUS 8242158*PED
- Jul 4, 2032patentUS 8242158*PED
- Jul 4, 2032patentUS 8338470*PED
- Jul 4, 2032patentUS 8338470*PED
- Jul 4, 2032patentUS 8338470*PED
- Jul 4, 2032patentUS 8455527*PED
- Jul 4, 2032patentUS 8455527*PED
- Jul 4, 2032patentUS 8455527*PED
- Jul 4, 2032patentUS 8648106*PED
- Jul 4, 2032patentUS 8648106*PED
- Jul 4, 2032patentUS 8648106*PED
- Jul 4, 2032patentUS 9320712*PED
- Jul 4, 2032patentUS 9320712*PED
- Jul 4, 2032patentUS 9320712*PED
- Jul 4, 2032patentUS 9616049*PED
- Jul 4, 2032patentUS 9616049*PED
- Jul 4, 2032patentUS 9616049*PED
- Jan 4, 2032formulationUS 10016396
- Jan 4, 2032formulationUS 10016396
- Jan 4, 2032formulationUS 8242158
- Jan 4, 2032formulationUS 8242158
- Jan 4, 2032formulationUS 8242158
- Jan 4, 2032formulationUS 8338470
- Jan 4, 2032formulationUS 8338470
- Jan 4, 2032formulationUS 8338470
- Jan 4, 2032method-of-use (U-421)US 8455527
- Jan 4, 2032method-of-use (U-421)US 8455527
- Jan 4, 2032method-of-use (U-421)US 8455527
- Jan 4, 2032formulationUS 8648106
- Jan 4, 2032formulationUS 8648106
- Jan 4, 2032formulationUS 8648106
- Jan 4, 2032formulationUS 9320712
- Jan 4, 2032formulationUS 9320712
- Jan 4, 2032formulationUS 9320712
- Jan 4, 2032formulationUS 9616049
- Jan 4, 2032formulationUS 9616049
- Jan 4, 2032formulationUS 9616049
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that